Ftse Mib
32.917,87
0,77%
DAX
18.068,21
0,26%
S&P 500
5.480,53
0,90%
NASDAQ
17.921,34
1,31%
Bitcoin
66.744,60
0,16%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Zymeworks Inc (ZYME) Zymeworks Inc (ZYME) Notizie

ZYME

Zymeworks (ZYME)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ZYME
DataOraFonteTitoloSimboloCompagnia
17/06/202412:00GlobeNewswire Inc.Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing CancersNASDAQ:ZYMEZymeworks Inc
10/06/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
10/06/202412:00GlobeNewswire Inc.Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract CancerNASDAQ:ZYMEZymeworks Inc
28/05/202412:30GlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
02/05/202422:05GlobeNewswire Inc.Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:ZYMEZymeworks Inc
11/04/202412:00GlobeNewswire Inc.Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024NASDAQ:ZYMEZymeworks Inc
08/04/202412:00GlobeNewswire Inc.Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual MeetingNASDAQ:ZYMEZymeworks Inc
28/03/202411:00GlobeNewswire Inc.Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of DirectorsNASDAQ:ZYMEZymeworks Inc
07/03/202422:46Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:ZYMEZymeworks Inc
07/03/202422:36Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:ZYMEZymeworks Inc
06/03/202423:25Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ZYMEZymeworks Inc
06/03/202422:09GlobeNewswire Inc.Zymeworks Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:ZYMEZymeworks Inc
05/03/202422:30GlobeNewswire Inc.Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual MeetingNASDAQ:ZYMEZymeworks Inc
14/02/202412:00GlobeNewswire Inc.Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference CallNASDAQ:ZYMEZymeworks Inc
08/02/202412:00GlobeNewswire Inc.Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of DirectorsNASDAQ:ZYMEZymeworks Inc
09/01/202400:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYMEZymeworks Inc
06/01/202403:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZYMEZymeworks Inc
04/01/202412:15GlobeNewswire Inc.Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025NASDAQ:ZYMEZymeworks Inc
04/01/202412:00GlobeNewswire Inc.Zymeworks Announces Additional Leadership AppointmentsNASDAQ:ZYMEZymeworks Inc
03/01/202422:32Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ZYMEZymeworks Inc
26/12/202314:00GlobeNewswire Inc.Zymeworks Announces $50 Million Private Placement to EcoR1 CapitalNASDAQ:ZYMEZymeworks Inc
15/12/202314:30GlobeNewswire Inc.Zymeworks Added to Nasdaq Biotechnology IndexNASDAQ:ZYMEZymeworks Inc
08/12/202323:03Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZYMEZymeworks Inc
30/11/202314:30GlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferenceNASDAQ:ZYMEZymeworks Inc
07/11/202322:05GlobeNewswire Inc.Zymeworks Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:ZYMEZymeworks Inc
17/10/202314:30GlobeNewswire Inc.Zymeworks To Host Third Quarter 2023 Results Conference CallNASDAQ:ZYMEZymeworks Inc
16/10/202322:30GlobeNewswire Inc.Zymeworks Announces New Director NomineeNASDAQ:ZYMEZymeworks Inc
10/08/202322:05GlobeNewswire Inc.Zymeworks Provides Corporate Update and Reports Second Quarter 2023 Financial ResultsNASDAQ:ZYMEZymeworks Inc
10/08/202313:12IH Market NewsThursday’s Wall Street Highlights: Capri Holdings, Disney, Sonos, Applovin, Plug Power, and moreNASDAQ:ZYMEZymeworks Inc
19/07/202314:30GlobeNewswire Inc.Zymeworks To Host Second Quarter 2023 Results Conference CallNASDAQ:ZYMEZymeworks Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ZYME

La tua Cronologia

BIT
UC7C6Z
Unicredit Bank
NYSE
PIM.W
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network